Buerger’s Disease Market Set to Surge with Innovative Cell Therapies
Buerger’s Disease, also known as thromboangiitis obliterans, is a rare vascular inflammatory disorder that primarily affects small- and medium-sized arteries and veins in the extremities. Standard treatment modalities have included smoking cessation support, anticoagulants, vasodilators, and surgical interventions. However, the evolving landscape of regenerative medicine has given rise to...
0 Comments 0 Shares 10 Views 0 Reviews